Exane Derivatives’s American Equity Investment Life Holding Company AEL Stock Holding History
Bought
Maintained
Sold
Other funds holding AEL
BC
RRAM
Exane Derivatives's AEL Position: Q3 2021 in Review
Exane Derivatives sold out of American Equity Investment Life Holding Company (AEL) in Q3 2021, closing a stake of 2,080 shares — an estimated $64.4K sold.
Exane Derivatives first reported a position in AEL in Q2 2021 and held it in 1 quarter. The position peaked at $64.4K in Q2 2021. 213 funds tracked by Wall St. Rank hold AEL as of Q3 2021.
- Exane Derivatives reported no remaining American Equity Investment Life Holding Company position as of Q3 2021 after selling out during the quarter.
- Exane Derivatives sold 2,080 American Equity Investment Life Holding Company shares in Q3 2021, an estimated $64.4K.
- Exane Derivatives first reported a position in American Equity Investment Life Holding Company in Q2 2021 and held it in 1 quarter.
- Exane Derivatives's American Equity Investment Life Holding Company position peaked at $64.4K in Q2 2021.
- 213 funds tracked by Wall St. Rank held American Equity Investment Life Holding Company as of Q3 2021.
Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.